Insider Transactions in Q1 2022 at Alteryx, Inc. (AYX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2022
|
Dean Stoecker Director |
SELL
Open market or private sale
|
Indirect |
20,000
-84.48%
|
$1,240,000
$62.62 P/Share
|
|
Mar 10
2022
|
Dean Stoecker Director |
BUY
Bona fide gift
|
Indirect |
20,000
+50.0%
|
-
|
|
Mar 10
2022
|
Dean Stoecker Director |
SELL
Bona fide gift
|
Indirect |
24,300
-58.85%
|
-
|
|
Mar 07
2022
|
Dean Stoecker Director |
BUY
Conversion of derivative security
|
Indirect |
24,300
+50.0%
|
-
|
|
Mar 07
2022
|
Alteryx, Inc. Director |
BUY
Conversion of derivative security
|
Indirect |
24,300
+50.0%
|
-
|
|
Mar 01
2022
|
Mark Anderson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,360
-11.09%
|
$526,680
$63.21 P/Share
|
|
Mar 01
2022
|
Scott Davidson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,280
-6.46%
|
$143,640
$63.21 P/Share
|
|
Mar 01
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,993
-5.03%
|
$377,559
$63.21 P/Share
|
|
Mar 01
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,090
-2.78%
|
$131,670
$63.21 P/Share
|
|
Mar 01
2022
|
Suresh Vittal Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,325
-2.9%
|
$272,475
$63.21 P/Share
|
|
Feb 25
2022
|
Suresh Vittal Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,979
+25.83%
|
-
|
|
Feb 25
2022
|
Christopher M Lal CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
27,722
+26.94%
|
-
|
|
Feb 25
2022
|
Kevin Rubin Interim CEO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
51,979
+30.39%
|
-
|
|
Feb 25
2022
|
Paula Hansen President & CRO |
BUY
Grant, award, or other acquisition
|
Direct |
51,979
+30.78%
|
-
|
|
Feb 24
2022
|
Jeff Horing |
BUY
Open market or private purchase
|
Indirect |
56,829
+1.26%
|
$3,125,595
$55.44 P/Share
|
|
Feb 23
2022
|
Jeff Horing |
BUY
Open market or private purchase
|
Indirect |
534,399
+19.03%
|
$29,391,945
$55.08 P/Share
|
|
Feb 22
2022
|
Jeff Horing |
BUY
Open market or private purchase
|
Indirect |
320,601
+31.59%
|
$17,312,454
$54.88 P/Share
|
|
Feb 18
2022
|
Timothy I Maudlin Director |
SELL
Open market or private sale
|
Direct |
9,233
-9.95%
|
$517,048
$56.07 P/Share
|
|
Feb 18
2022
|
Timothy I Maudlin Director |
BUY
Conversion of derivative security
|
Direct |
43,000
+47.9%
|
-
|
|
Feb 07
2022
|
Chris Natali Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,195
+50.0%
|
-
|
|
Jan 01
2022
|
Scott Davidson Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,767
-9.64%
|
$226,020
$60.5 P/Share
|
|
Jan 01
2022
|
Christopher M Lal CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
3,087
-6.15%
|
$185,220
$60.5 P/Share
|
|
Jan 01
2022
|
Dean Stoecker Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14,056
-15.04%
|
$843,360
$60.5 P/Share
|
|
Jan 01
2022
|
Kevin Rubin Interim CEO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,228
-8.54%
|
$373,680
$60.5 P/Share
|